|
Transgenic T cells with enhanced anti-tumor cytotoxicity to treat cancers
CAR T cell therapy recently achieved success in treating blood cancers. Drugs Kymriah and Yescarta are FDA approved for treating hematological malignancies. However, existing T cell therapies are not effective in treating solid tumors, partly due to T cell exhaustion and lack of sufficient memory T cell populations.
GW researchers invented a way to...
Published: 2/18/2025
|
Inventor(s): Rong Li, Bogang Wu
Keywords(s):
Category(s): Technology Classifications > Therapeutics > Cells
|
